Cellular, molecular, and clinical mechanisms of action of deep brain stimulation—a systematic review on established indications and outlook on future developments

Abstract Deep brain stimulation (DBS) has been successfully used to treat movement disorders, such as Parkinson's disease, for more than 25 years and heralded the advent of electrical neuromodulation to treat diseases with dysregulated neuronal circuits. DBS is now superseding ablative techniqu...

Full description

Saved in:
Bibliographic Details
Main Authors: Martin Jakobs, Anton Fomenko, Andres M Lozano, Karl L Kiening
Format: Article
Language:English
Published: Springer Nature 2019-03-01
Series:EMBO Molecular Medicine
Subjects:
Online Access:https://doi.org/10.15252/emmm.201809575
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849761569676722176
author Martin Jakobs
Anton Fomenko
Andres M Lozano
Karl L Kiening
author_facet Martin Jakobs
Anton Fomenko
Andres M Lozano
Karl L Kiening
author_sort Martin Jakobs
collection DOAJ
description Abstract Deep brain stimulation (DBS) has been successfully used to treat movement disorders, such as Parkinson's disease, for more than 25 years and heralded the advent of electrical neuromodulation to treat diseases with dysregulated neuronal circuits. DBS is now superseding ablative techniques, such as stereotactic radiofrequency lesions. While serendipity has played a role in developing DBS as a therapy, research during the past two decades has shown that electrical neuromodulation is far more than a functional lesion that can be switched on and off. This understanding broadens the field to enable new types of stimulation, clinical indications, and research. This review highlights the complex effects of DBS from the single cell to the neuronal network. Specifically, we examine the electrical, cellular, molecular, and neurochemical mechanisms of DBS as applied to Parkinson's disease and other emerging applications.
format Article
id doaj-art-e0c539c92b674d088f90b17f8bd36ce3
institution DOAJ
issn 1757-4676
1757-4684
language English
publishDate 2019-03-01
publisher Springer Nature
record_format Article
series EMBO Molecular Medicine
spelling doaj-art-e0c539c92b674d088f90b17f8bd36ce32025-08-20T03:06:00ZengSpringer NatureEMBO Molecular Medicine1757-46761757-46842019-03-0111411810.15252/emmm.201809575Cellular, molecular, and clinical mechanisms of action of deep brain stimulation—a systematic review on established indications and outlook on future developmentsMartin Jakobs0Anton Fomenko1Andres M Lozano2Karl L Kiening3Department of Neurosurgery, University Hospital HeidelbergDivision of Neurosurgery, Toronto Western Hospital, University Health NetworkDivision of Neurosurgery, Toronto Western Hospital, University Health NetworkDepartment of Neurosurgery, University Hospital HeidelbergAbstract Deep brain stimulation (DBS) has been successfully used to treat movement disorders, such as Parkinson's disease, for more than 25 years and heralded the advent of electrical neuromodulation to treat diseases with dysregulated neuronal circuits. DBS is now superseding ablative techniques, such as stereotactic radiofrequency lesions. While serendipity has played a role in developing DBS as a therapy, research during the past two decades has shown that electrical neuromodulation is far more than a functional lesion that can be switched on and off. This understanding broadens the field to enable new types of stimulation, clinical indications, and research. This review highlights the complex effects of DBS from the single cell to the neuronal network. Specifically, we examine the electrical, cellular, molecular, and neurochemical mechanisms of DBS as applied to Parkinson's disease and other emerging applications.https://doi.org/10.15252/emmm.201809575circuitopathiesdeep brain stimulationmovement disordersneuromodulationParkinson's disease
spellingShingle Martin Jakobs
Anton Fomenko
Andres M Lozano
Karl L Kiening
Cellular, molecular, and clinical mechanisms of action of deep brain stimulation—a systematic review on established indications and outlook on future developments
EMBO Molecular Medicine
circuitopathies
deep brain stimulation
movement disorders
neuromodulation
Parkinson's disease
title Cellular, molecular, and clinical mechanisms of action of deep brain stimulation—a systematic review on established indications and outlook on future developments
title_full Cellular, molecular, and clinical mechanisms of action of deep brain stimulation—a systematic review on established indications and outlook on future developments
title_fullStr Cellular, molecular, and clinical mechanisms of action of deep brain stimulation—a systematic review on established indications and outlook on future developments
title_full_unstemmed Cellular, molecular, and clinical mechanisms of action of deep brain stimulation—a systematic review on established indications and outlook on future developments
title_short Cellular, molecular, and clinical mechanisms of action of deep brain stimulation—a systematic review on established indications and outlook on future developments
title_sort cellular molecular and clinical mechanisms of action of deep brain stimulation a systematic review on established indications and outlook on future developments
topic circuitopathies
deep brain stimulation
movement disorders
neuromodulation
Parkinson's disease
url https://doi.org/10.15252/emmm.201809575
work_keys_str_mv AT martinjakobs cellularmolecularandclinicalmechanismsofactionofdeepbrainstimulationasystematicreviewonestablishedindicationsandoutlookonfuturedevelopments
AT antonfomenko cellularmolecularandclinicalmechanismsofactionofdeepbrainstimulationasystematicreviewonestablishedindicationsandoutlookonfuturedevelopments
AT andresmlozano cellularmolecularandclinicalmechanismsofactionofdeepbrainstimulationasystematicreviewonestablishedindicationsandoutlookonfuturedevelopments
AT karllkiening cellularmolecularandclinicalmechanismsofactionofdeepbrainstimulationasystematicreviewonestablishedindicationsandoutlookonfuturedevelopments